JPS6113683B2 - - Google Patents
Info
- Publication number
- JPS6113683B2 JPS6113683B2 JP19415482A JP19415482A JPS6113683B2 JP S6113683 B2 JPS6113683 B2 JP S6113683B2 JP 19415482 A JP19415482 A JP 19415482A JP 19415482 A JP19415482 A JP 19415482A JP S6113683 B2 JPS6113683 B2 JP S6113683B2
- Authority
- JP
- Japan
- Prior art keywords
- enteric
- cephalexin
- granules
- component
- fast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008187 granular material Substances 0.000 claims description 38
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 claims description 30
- 229940106164 cephalexin Drugs 0.000 claims description 30
- 238000002360 preparation method Methods 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 13
- 239000002702 enteric coating Substances 0.000 claims description 9
- 238000009505 enteric coating Methods 0.000 claims description 9
- 235000021355 Stearic acid Nutrition 0.000 claims description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 6
- 239000008117 stearic acid Substances 0.000 claims description 6
- 239000000454 talc Substances 0.000 claims description 6
- 229910052623 talc Inorganic materials 0.000 claims description 6
- 229920001800 Shellac Polymers 0.000 claims description 5
- 239000010410 layer Substances 0.000 claims description 5
- 239000004014 plasticizer Substances 0.000 claims description 5
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims description 5
- 239000004208 shellac Substances 0.000 claims description 5
- 229940113147 shellac Drugs 0.000 claims description 5
- 235000013874 shellac Nutrition 0.000 claims description 5
- 238000013268 sustained release Methods 0.000 claims description 5
- 239000012730 sustained-release form Substances 0.000 claims description 5
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 3
- 239000011324 bead Substances 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 229920003145 methacrylic acid copolymer Polymers 0.000 claims description 3
- 239000003405 delayed action preparation Substances 0.000 claims description 2
- 239000010419 fine particle Substances 0.000 claims description 2
- 239000007903 gelatin capsule Substances 0.000 claims description 2
- 235000012222 talc Nutrition 0.000 claims description 2
- 238000000576 coating method Methods 0.000 description 10
- 239000011248 coating agent Substances 0.000 description 9
- 239000002245 particle Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000007931 coated granule Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000007922 dissolution test Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000011247 coating layer Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- -1 glycerin fatty acid ester Chemical class 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 206010056396 Asymptomatic bacteriuria Diseases 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229920003136 Eudragit® L polymer Polymers 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical class OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960004016 sucrose syrup Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19415482A JPS5982311A (ja) | 1982-11-04 | 1982-11-04 | セフアレキシン持効性製剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19415482A JPS5982311A (ja) | 1982-11-04 | 1982-11-04 | セフアレキシン持効性製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5982311A JPS5982311A (ja) | 1984-05-12 |
| JPS6113683B2 true JPS6113683B2 (enrdf_load_stackoverflow) | 1986-04-15 |
Family
ID=16319813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP19415482A Granted JPS5982311A (ja) | 1982-11-04 | 1982-11-04 | セフアレキシン持効性製剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5982311A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62213720A (ja) * | 1986-03-14 | 1987-09-19 | 株式会社 サンコ− | 便座カバ−及びその製造方法 |
| JPS62181299U (enrdf_load_stackoverflow) * | 1986-05-07 | 1987-11-17 |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62226926A (ja) * | 1986-03-27 | 1987-10-05 | Teisan Seiyaku Kk | 持続性複合顆粒剤 |
| JPH0714863B2 (ja) * | 1986-06-02 | 1995-02-22 | 忠生 白石 | 時差溶解性の入浴剤 |
| US5395626A (en) * | 1994-03-23 | 1995-03-07 | Ortho Pharmaceutical Corporation | Multilayered controlled release pharmaceutical dosage form |
| JPH09188617A (ja) * | 1996-01-08 | 1997-07-22 | Pola Chem Ind Inc | 徐放性医薬組成物 |
| US6322819B1 (en) | 1998-10-21 | 2001-11-27 | Shire Laboratories, Inc. | Oral pulsed dose drug delivery system |
| AU2001241192A1 (en) * | 2000-03-23 | 2001-10-03 | Shionogi And Co., Ltd. | Enteric granular preparations of hardly water soluble drugs characterized by containing water-repellent component |
| PT1667665E (pt) * | 2003-09-03 | 2009-02-13 | Pharmaton Sa | Cápsulas contendo grânulos de substâncias activas com perfis de libertação distintos |
| AU2006235483B2 (en) * | 2005-04-12 | 2010-11-25 | Elan Pharma International Limited | Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection |
| US8846100B2 (en) | 2006-05-12 | 2014-09-30 | Shire Llc | Controlled dose drug delivery system |
| US12383504B2 (en) | 2012-05-21 | 2025-08-12 | Capsugel Belgium Nv | Acid resistant banding solution for two piece hard capsules |
| JP2016164149A (ja) * | 2015-02-27 | 2016-09-08 | 尾木 大 | コーティング剤組成物 |
-
1982
- 1982-11-04 JP JP19415482A patent/JPS5982311A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62213720A (ja) * | 1986-03-14 | 1987-09-19 | 株式会社 サンコ− | 便座カバ−及びその製造方法 |
| JPS62181299U (enrdf_load_stackoverflow) * | 1986-05-07 | 1987-11-17 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5982311A (ja) | 1984-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI78835C (fi) | Foerfarande foer framstaellning av en ny dipyridamol-retardform. | |
| AU2001255509B2 (en) | Taste masking coating composition | |
| US4427648A (en) | Dipyridamole-containing pharmaceutical form | |
| EP1276470B1 (en) | Taste masking coating composition | |
| EP0129382B1 (en) | Long-acting formulation of cefaclor and its preparation | |
| CA1248023A (en) | Diffusion coated multiple-units dosage form | |
| KR880001753B1 (ko) | 브롬헥신 서방출성 제형의 제조방법 | |
| JPH0122245B2 (enrdf_load_stackoverflow) | ||
| NZ205894A (en) | Pharmaceutical compositions containing mopidamol(2,6-bis(diethanolamino)-4-piperidino-pyrimido(5,4-d)pyrimidine) | |
| HU227971B1 (en) | Tramadol multiple unit formulations and process for producing them | |
| HK1001554B (en) | Diffusion coated multiple-units dosage form | |
| JP2000514051A (ja) | ベンズイミダゾール誘導体を活性成分とする経口投与用の安定な薬剤形およびその製造方法 | |
| AU2009247921B2 (en) | Solid oral form with dual release profile, containing multiparticulates | |
| JPS6113683B2 (enrdf_load_stackoverflow) | ||
| PT1954251E (pt) | Composição de libertação prolongada da substância ativa, seu método de preparação e sua utilização | |
| JP2004507487A (ja) | 腸疾患治療薬 | |
| CA1099641A (en) | Pharmaceutical composition containing chromone derivatives | |
| US3485914A (en) | Process for the production of a pharmaceutical antibiotic preparation having delayed therapeutic action and the composition prepared according to such process | |
| JPH04103525A (ja) | 難水溶性薬物の持続性製剤化方法 | |
| JPS6339814A (ja) | トラニラストの経口用持続性製剤 | |
| KR20110012638A (ko) | 담즙 분비 증강 및 간장 질환에 의한 간기능 개선 치료 의약 조성물 | |
| JPS61221116A (ja) | 錠剤の組成物 | |
| KR100505898B1 (ko) | 철분함유 고밀도 펠렛 조성물 및 이의 제조방법 | |
| DE10149652A1 (de) | Mittel zur peroralen Verabreichung von Natriumbenzoat, seine Herstellung und Verwendung |